Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
BMJ Open|February 11, 2017
Patient and physician attitudes regarding risk and benefit in streamlined development programmes for antibacterial drugs: a qualitative analysisThomas L Holland, Stephen Mikita, Diane Bloom, et al.
The Oncologist|June 12, 2019
Secondary Use of Patient Tissue in Cancer BiobanksDebra J H Mathews, Julia T Rabin, Katharine Quain, et al.
Annals of Surgical Oncology|May 13, 2016
Surgeons' Perspectives of Contralateral Prophylactic MastectomyEmily Bellavance, Jeffrey Peppercorn, Shari Kronsberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful ActivityValsamo Anagnostou, Mark Yarchoan, Aaron R Hansen, et al.
The Oncologist|September 8, 2019
Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is UnclearJeffrey Peppercorn, Eric Campbell, Steve Isakoff, et al.
Cancers|November 13, 2025
Exploring the Priorities of Patients with Early Breast Cancer in the United States: A Qualitative Interview Study and Patient-Informed Conceptual Disease ModelAshley Duenas, Zulikhat Segunmaru, Deborah Collyar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
Immuno-oncology Clinical Trial Design: Limitations, Challenges, and OpportunitiesChristina S Baik, Eric H Rubin, Patrick M Forde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Ethics of mandatory research biopsy for correlative end points within clinical trials in oncologyJeffrey Peppercorn, Iuliana Shapira, Deborah Collyar, et al.
Journal of the National Cancer Institute|April 22, 2004
Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participantsAnn H Partridge, Nadia Hackett, Emily Blood, et al.
BMJ Open|March 14, 2019
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)E Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
Pageof 6